Neola Medical AB (publ) (STO:NEOLA)
Sweden · Delayed Price · Currency is SEK 0.9980
-0.0720 (-6.73%)
Jan 21, 2026, 3:46 PM CET
Neola Medical AB Company Description
Neola Medical AB (publ), together with its subsidiary, Neola Medical, Inc., develops medical technology devices for non-invasive continuous monitoring of the lungs of preterm born infants in Sweden.
It offers NEOLA, a neonatal intensive care medical device that enables continuous lung monitoring and real-time alerts of life-threatening complications using technology that measures lung volume changes and oxygen gas concentration.
The company was formerly known as GPX Medical AB and changed its name to Neola Medical AB (publ) in June 2022.
Neola Medical AB (publ) was incorporated in 2016 and is headquartered in Lund, Sweden.
Neola Medical AB (publ)
| Country | Sweden |
| Founded | 2016 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 8 |
| CEO | Hanna Sjostrom |
Contact Details
Address: Ideon Gateway Lund, 223 63 Sweden | |
| Website | neolamedical.com |
Stock Details
| Ticker Symbol | NEOLA |
| Exchange | Nasdaq Stockholm |
| Fiscal Year | January - December |
| Reporting Currency | SEK |
| ISIN Number | SE0014829255 |
| SIC Code | 3845 |
Key Executives
| Name | Position |
|---|---|
| Hanna Sjostrom | Chief Executive Officer and MD |
| David Folkesson | Chief Financial Officer |
| Sara Bergsten | Chief Technology Officer |
| Magnus Johnsson | Director Quality Assurance and Regulatory Affairs |